학술논문
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib study
Document Type
Article
Author
Lasater, E.A.; Mali, R.S.; Oeh, J.; Ingalla, E.R.; Go, M.; Yu, S.-F.; Polson, A.G.; Sampath, D.; Amin, D.N.; Lin, E.; Martin, S.; Wertz, I.E.; Bannerji, R.; Barrett, K.; Jiang, Y.; Rys, R.N.; Wever, C.; Johnson, N.A.; Sterne-Weiler, T.; Chang, M.T.; Krem, M.M.; Arthur, C.; Hahn, U.; Johnston, A.; Karur, V.; Khan, N.; Marlton, P.; Phillips, T.; Gritti, G.; Seymour, J.F.; Tani, M.; Yuen, S.; Rose, C.M.; Pham, V.C.; Chang, Y.; Hirata, J.; Musick, L.; Flowers, C.R.
Source
In: American Journal of Hematology . (American Journal of Hematology, March 2023, 98(3):449-463)
Subject
Language
English
ISSN
10968652
03618609
03618609